1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with aminopropionitrile in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hartmann, S; Lutz, S; Ridley, A; Santos, GL; Zimmermann, WH | 1 |
1 other study(ies) available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and aminopropionitrile
| Article | Year |
|---|---|
Inhibition of Rho-associated kinases suppresses cardiac myofibroblast function in engineered connective and heart muscle tissues.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Actins; Aminopropionitrile; Animals; Cell Differentiation; Cells, Cultured; Collagen; Extracellular Matrix; Fibrosis; Heart; Humans; Male; Myocardium; Myofibroblasts; Protein-Lysine 6-Oxidase; Rats; Rats, Wistar; rho-Associated Kinases; Signal Transduction; Transforming Growth Factor beta | 2019 |